These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 23291073

  • 1. [A prospective randomized controlled clinical trial of irinotecan plus cisplatin versus gemcitabine plus cisplatin as a first-line treatment for advanced non-small cell lung cancer].
    Zhao WY, Chen DY.
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):775-9. PubMed ID: 23291073
    [Abstract] [Full Text] [Related]

  • 2. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.
    Han JY, Lee DH, Song JE, Lee SY, Kim HY, Kim HT, Lee JS.
    Cancer; 2008 Jul 15; 113(2):388-95. PubMed ID: 18484595
    [Abstract] [Full Text] [Related]

  • 3. ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer.
    Han JY, Lee GK, Lim KY, Lee YJ, Nam BH, Lee JS.
    Cancer Res Treat; 2017 Jul 15; 49(3):678-687. PubMed ID: 27737534
    [Abstract] [Full Text] [Related]

  • 4. [A randomized trial of docetaxol plus cisplatin versus gemzar plus cisplatin in treating advanced non-small cell lung cancer].
    Gao Y, Shi ZQ, Cao CW, Zhu CL, Guo J.
    Ai Zheng; 2005 Aug 15; 24(8):985-9. PubMed ID: 16086878
    [Abstract] [Full Text] [Related]

  • 5. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.
    Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M.
    Ann Oncol; 2007 Feb 15; 18(2):317-23. PubMed ID: 17079694
    [Abstract] [Full Text] [Related]

  • 6. Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study.
    Georgoulias V, Agelidou A, Syrigos K, Rapti A, Agelidou M, Nikolakopoulos J, Polyzos A, Athanasiadis A, Tselepatiotis E, Androulakis N, Kalbakis K, Samonis G, Mavroudis D.
    Br J Cancer; 2005 Oct 03; 93(7):763-9. PubMed ID: 16175189
    [Abstract] [Full Text] [Related]

  • 7. Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II study.
    Pectasides D, Mylonakis N, Farmakis D, Nikolaou M, Koumpou M, Katselis I, Gaglia A, Kostopoulou V, Karabelis A, Kosmas C.
    Anticancer Res; 2003 Oct 03; 23(5b):4205-11. PubMed ID: 14666626
    [Abstract] [Full Text] [Related]

  • 8. Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.
    Georgoulias V, Kouroussis C, Agelidou A, Boukovinas I, Palamidas P, Stavrinidis E, Polyzos A, Syrigos K, Veslemes M, Toubis M, Ardavanis A, Tselepatiotis E, Vlachonikolis I, Lung Cancer Committee of the Hellenic Oncology Research Group.
    Br J Cancer; 2004 Aug 02; 91(3):482-8. PubMed ID: 15238986
    [Abstract] [Full Text] [Related]

  • 9. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].
    Zhang L, Zhang Y, Li N, Xu F, Pan ZK, Guan ZZ.
    Ai Zheng; 2004 Nov 02; 23(11 Suppl):1455-8. PubMed ID: 15566656
    [Abstract] [Full Text] [Related]

  • 10. [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].
    Liu L, Wang XW, Li L, Zhang X, Zhang WD, Yu XJ.
    Ai Zheng; 2006 Aug 02; 25(8):990-4. PubMed ID: 16965680
    [Abstract] [Full Text] [Related]

  • 11. Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).
    Kentepozidis N, Economopoulou P, Christofyllakis C, Chelis L, Polyzos A, Vardakis N, Koinis F, Vamvakas L, Katsaounis P, Kalbakis K, Nikolaou C, Georgoulias V, Kotsakis A.
    Clin Transl Oncol; 2017 Mar 02; 19(3):317-325. PubMed ID: 27492015
    [Abstract] [Full Text] [Related]

  • 12. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V, Galetta D, Caruso M, Verderame F, Pezzella G, Valdesi M, Borsellino N, Pandolfo G, Durini E, Rinaldi M, Loizzi M, Gebbia N, Valenza R, Tirrito ML, Varvara F, Colucci G, Gruppo Ocologico Italia Meridionale.
    Lung Cancer; 2003 Feb 02; 39(2):179-89. PubMed ID: 12581571
    [Abstract] [Full Text] [Related]

  • 13. A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
    Kosmas C, Tsavaris N, Syrigos K, Koutras A, Tsakonas G, Makatsoris T, Mylonakis N, Karabelis A, Stathopoulos GP, Kalofonos HP.
    Cancer Chemother Pharmacol; 2007 Jan 02; 59(1):51-9. PubMed ID: 16622691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.
    Han JY, Nam BH, Kim HY, Yoon SJ, Kim HT, Lee JS.
    Ann Oncol; 2012 Nov 02; 23(11):2925-2930. PubMed ID: 22782331
    [Abstract] [Full Text] [Related]

  • 16. Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia.
    Nakamura Y, Soda H, Oka M, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Nagashima S, Soejima Y, Kasai T, Nakatomi K, Masuda N, Tsukamoto K, Kohno S.
    J Thorac Oncol; 2011 Jan 02; 6(1):121-7. PubMed ID: 21150467
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC.
    Rocha Lima CM, Rizvi NA, Zhang C, Herndon JE, Crawford J, Govindan R, King GW, Green MR, Cancer Leukemia Group B.
    Ann Oncol; 2004 Mar 02; 15(3):410-8. PubMed ID: 14998842
    [Abstract] [Full Text] [Related]

  • 18. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
    Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtů H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T, Kůta M.
    Lung Cancer; 2003 Sep 02; 41(3):321-31. PubMed ID: 12928123
    [Abstract] [Full Text] [Related]

  • 19. Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
    Jang J, Kim HK, Cho BC, Lee KH, Yun HJ, Woo IS, Song HS, Ryoo HM, Kim CH, Sun DS, Shin JW.
    Cancer Chemother Pharmacol; 2017 May 02; 79(5):873-880. PubMed ID: 28341958
    [Abstract] [Full Text] [Related]

  • 20. A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.
    Kakolyris SS, Kouroussis C, Koukourakis M, Kalbakis K, Mavroudis D, Vardakis N, Georgoulias V.
    Anticancer Res; 2002 May 02; 22(3):1891-6. PubMed ID: 12168889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.